Lonza | LONN - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Akzo Nobel EUR 4.88B 222M 2026-03
Alcon AG USD 22.13B 99M 2026-03
Almirall EUR 1.49B 24.03M 2025-12
AstraZeneca USD 47.33B 1.33B 2026-03
BASF EUR 33.2B 434M 2025-12
Bayer EUR 28.85B 2.9B 2026-03
Beiersdorf EUR 8.6B 133M 2025-12
Covestro EUR 7B 908M 2025-12
Demant DKK 9.84B 446M 2025-12
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Geberit CHF 1.54B 237.4M 2025-03
Genmab DKK 5.85B 96M 2025-12
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GN Store Nord DKK 10.12B 4.76B 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Johnson Matthey GBP 2.02B 85M 2026-06
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Philips EUR 11.39B 403M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Sika AG CHF 6.66B 481.4M 2025-12
Smith & Nephew USD 5.54B 331M 2025-12
Solvay EUR 1.18B 161M 2026-03
UCB EUR 10.87B 1.18B 2025-12